![]() Halozyme Therapeutics Halozyme Therapeutics is a biotechnology company focused on developing and commercializing cancer therapies that target the tumor microenvironment. | ![]() Puma Biotechnology Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer. | ||
Founding Date | Founding Date 1994 | Founding Date 1998 | Founding Date 2010 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Alameda, US HQ | Locations San Diego, US HQ | Locations Los Angeles, US HQ |
Employees | Employees 1,14712% decrease | Employees 373157% increase | Employees 27214% decrease |
Valuation ($) | Valuation ($) 8.2 b | Valuation ($) 6.4 b | Valuation ($) 136.8 m |
Financial | |||
Revenue (est.) | Revenue (est.) $2.3b (FY, 2025) | Revenue (est.) $1.4b (FY, 2025) | Revenue (est.) $228.4m (FY, 2025) |
Cost of goods | Cost of goods $83.7m (FY, 2025) | Cost of goods $228.8m (FY, 2025) | Cost of goods $58.2m (FY, 2025) |
Gross profit | Gross profit $2.2b (FY, 2025) | Gross profit $1.2b (FY, 2025) | Gross profit $170.2m (FY, 2025) |
Net income | Net income $782.6m (FY, 2025) | Net income $316.9m (FY, 2025) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 171.9m | Total funding raised $ 172m |

Halozyme Therapeutics is a biotechnology company focused on developing and commercializing cancer therapies that target the tumor microenvironment.
View company
Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer.
View company